These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 29791474)

  • 1. Growth differentiation factor-15 levels and the risk of contrast induced nephropathy in patients with acute myocardial infarction undergoing percutaneous coronary intervention: A retrospective observation study.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(5):e0197609. PubMed ID: 29791474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth differentiation factor-15 levels and the risk of contrast induced acute kidney injury in acute myocardial infarction patients treated invasively: A propensity-score match analysis.
    Sun L; Zhou X; Jiang J; Zang X; Chen X; Li H; Cao H; Wang Q
    PLoS One; 2018; 13(3):e0194152. PubMed ID: 29529072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.
    Liu Y; Tan N; Zhou YL; Chen YY; Chen JY; Chen J; Luo JF
    J Nephrol; 2012; 25(3):332-40. PubMed ID: 21928234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].
    He YT; Tan N; Liu YH; Chen SQ; Liu Y; Huang SJ; Yang DH; Ye P; Ran P
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):394-8. PubMed ID: 24021122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Gamma-Glutamyl Transferase Levels for Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention.
    Oksuz F; Yarlioglues M; Cay S; Celik IE; Mendi MA; Kurtul A; Cankurt T; Kuyumcu S; Canpolat U; Turak O
    Am J Cardiol; 2015 Sep; 116(5):711-6. PubMed ID: 26116992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Relationship between thrombolysis in myocardial infarction risk index and the severity of coronary artery lesions and long-term outcome in acute myocardial infarction patients undergoing percutaneous coronary intervention].
    Chen Y; Song Y; Xu JJ; Tang XF; Wang HH; Jiang P; Jiang L; Liu R; Zhao XY; Gao LJ; Song L; Zhang Y; Chen J; Gao Z; Qiao SB; Yang YJ; Gao RL; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Nov; 46(11):874-881. PubMed ID: 30462976
    [No Abstract]   [Full Text] [Related]  

  • 8. Creatine kinase-MB and red cell distribution width as predictors of contrast-induced nephropathy after percutaneous coronary intervention in acute myocardial infarction.
    Zbierska-Rubinkiewicz K; Trębacz O; Tomala M; Rubinkiewicz M; Chrzan I; Gackowski A
    Folia Med Cracov; 2017; 57(3):87-99. PubMed ID: 29263458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Andò G; Morabito G; de Gregorio C; Trio O; Saporito F; Oreto G
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):878-85. PubMed ID: 23703775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of preprocedural high-sensitivity C-reactive protein on contrast-induced nephropathy in patients undergoing primary percutaneous coronary intervention.
    Jian-Wei Z; Yu-Jie Z; Shu-Jun C; Qing Y; Shi-Wei Y; Bin N
    Angiology; 2014 May; 65(5):402-7. PubMed ID: 23539615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Induced Nephropathy and Long-Term Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
    Sun G; Chen P; Wang K; Li H; Chen S; Liu J; He Y; Song F; Liu Y; Chen JY
    Angiology; 2019 Aug; 70(7):621-626. PubMed ID: 30317864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
    Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
    Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diastolic dysfunction predicts the risk of contrast-induced nephropathy and outcome post-emergency percutaneous coronary intervention in AMI patients with preserved ejection fraction.
    Han B; Li Y; Dong Z; Wan Q; Shen H; Li J; Wei M; Shen C
    Heart Vessels; 2018 Oct; 33(10):1149-1158. PubMed ID: 29704102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Female gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarction.
    Lucreziotti S; Centola M; Salerno-Uriarte D; Ponticelli G; Battezzati PM; Castini D; Sponzilli C; Lombardi F
    Int J Cardiol; 2014 Jun; 174(1):37-42. PubMed ID: 24698233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum GDF-15 Predicts In-Hospital Mortality and Arrhythmic Risks in Patients With Acute Myocardial Infarction.
    Mo Q; Zhuo L; Liao Z; Li R; Chen Y; Geng J
    Clin Appl Thromb Hemost; 2022; 28():10760296211063875. PubMed ID: 35001647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction.
    Khan SQ; Ng K; Dhillon O; Kelly D; Quinn P; Squire IB; Davies JE; Ng LL
    Eur Heart J; 2009 May; 30(9):1057-65. PubMed ID: 19168526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of C-Reactive Protein as a Predictor of Contrast-Induced Nephropathy After Percutaneous Coronary Interventions in Patients With Acute Myocardial Infarction and Presentation of a New Risk Score (Athens CIN Score).
    Lazaros G; Zografos T; Oikonomou E; Siasos G; Georgiopoulos G; Vavuranakis M; Antonopoulos A; Kalogeras K; Tsalamandris S; Tousoulis D
    Am J Cardiol; 2016 Nov; 118(9):1329-1333. PubMed ID: 27745963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of central pulse pressure with contrast-induced nephropathy and clinical outcomes in patients undergoing coronary intervention.
    Huang SS; Huang PH; Leu HB; Wu TC; Lin SJ; Chen JW
    J Hypertens; 2013 Nov; 31(11):2187-94. PubMed ID: 23868087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.